Početna › Veliki depresivni poremećaj › Missouri
Kliničke studije za Veliki depresivni poremećaj u državi Missouri
16 studija za Veliki depresivni poremećaj traži sudionike na lokacijama u državi Missouri.
Gradovi u državi Missouri
Službeni tekst studije (engleski)
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Psychiatric Care and Research Center (PCRC), O'Fallon
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT05850689Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Saint Charles
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06830044Lumateperone for Late-Life Depression
- Washington University School of Medicine, St Louis
U tijeku regrutacijaFaza 3
Od 60 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07623135A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, St Louis
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- St. Charles Psychiatric Associates, Inc. dba Midwest Research Group, Saint Charles
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07284667A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Psychiatric Care and Research Center, O'Fallon
- St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07076407Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Washington University School of Medicine, St Louis
U tijeku regrutacija
Od 22 do 70 godina · Oba spola · Ažurirano 28. kol 2026. · NCT06423430A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Arch Clinical Trials, LLC, St Louis
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Arch Clinical Trials, St Louis
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 6. kol 2026. · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Tekton Research, St Louis
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06775379A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, O'Fallon
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. srp 2026. · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, O'Fallon
- Neurocrine Clinical Site, Saint Charles
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. srp 2026. · NCT06966401A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Midwest Research Group, Saint Charles
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 11. svi 2026. · NCT06524830NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits
- Washington University School of Medicine, St Louis
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 65 godina · Oba spola · Ažurirano 29. tra 2026. · NCT02994433Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #127, Saint Charles
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 20. sij 2026. · NCT06633016A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Saint Charles
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 23. sij 2025. · NCT06223880Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.